Log In
Sunday 27th May 2018

regulators' data request means painful wait for MS sufferers

23rd July 2007

The Medicines and Healthcare Regulatory Agency (MHRA) met last week to discuss Sativex, a medicinal form of cannabis.  It decided more clinical data was needed before the drug could be approved for treating muscle stiffness in MS patients.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018